Surgery Partners Inc
NASDAQ:SGRY
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
19.61
35.07
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Surgery Partners Inc
Surgery Partners Inc
EPS (Diluted)
Surgery Partners Inc
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Surgery Partners Inc
NASDAQ:SGRY
|
EPS (Diluted)
$0
|
CAGR 3-Years
23%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
Universal Health Services Inc
NYSE:UHS
|
EPS (Diluted)
$15
|
CAGR 3-Years
6%
|
CAGR 5-Years
13%
|
CAGR 10-Years
12%
|
|
|
Encompass Health Corp
NYSE:EHC
|
EPS (Diluted)
$4
|
CAGR 3-Years
0%
|
CAGR 5-Years
5%
|
CAGR 10-Years
11%
|
|
|
Tenet Healthcare Corp
NYSE:THC
|
EPS (Diluted)
$32
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
HCA Healthcare Inc
NYSE:HCA
|
EPS (Diluted)
$22
|
CAGR 3-Years
4%
|
CAGR 5-Years
18%
|
CAGR 10-Years
19%
|
|
|
Ensign Group Inc
NASDAQ:ENSG
|
EPS (Diluted)
$4
|
CAGR 3-Years
7%
|
CAGR 5-Years
16%
|
CAGR 10-Years
17%
|
|
Surgery Partners Inc
Glance View
Surgery Partners Inc., a prominent player in the healthcare industry, orchestrates a robust network of surgical facilities across the United States. The company's business model is centered around operating and acquiring a variety of healthcare services, primarily focusing on short-stay surgeries through its ambulatory surgery centers, surgical hospitals, and ancillary services. Founded in 2004, Surgery Partners has grown its footprint by honing in on cost-effective, high-quality outpatient surgery, offering a compelling alternative to traditional hospital settings. This approach not only reduces healthcare costs for patients and insurers but also provides an efficient model for physicians looking to practice in specialized surgical environments. Revenue generation for Surgery Partners is multifaceted, deriving primarily from patient service fees and strategic partnerships with healthcare providers and insurers. By maintaining a diversified portfolio that includes musculoskeletal surgeries, cardiac procedures, and other specialist operations, the company captures a broad spectrum of medical needs. Additionally, it benefits from ancillary services such as anesthesia and pathology, which are critical components of the surgical process. This integrated service offering allows Surgery Partners to maximize revenue streams while maintaining a strong presence in the outpatient surgery market. The company’s collaborative approach, working closely with physicians and leveraging strategic acquisitions, fortifies its position as a leader in the evolution toward more efficient, patient-centric healthcare delivery.
See Also
What is Surgery Partners Inc's EPS (Diluted)?
EPS (Diluted)
-0.5
USD
Based on the financial report for Sep 30, 2024, Surgery Partners Inc's EPS (Diluted) amounts to -0.5 USD.
What is Surgery Partners Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
37%
Over the last year, the EPS (Diluted) growth was -78%. The average annual EPS (Diluted) growth rates for Surgery Partners Inc have been 23% over the past three years , 37% over the past five years .
You don't have any saved screeners yet
